The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers
Status:
Completed
Trial end date:
2015-12-23
Target enrollment:
Participant gender:
Summary
This study will test if a study drug (CS-3150) will affect the heart rate in healthy males
and females. Two doses of the study drug will be tested. Heart rate is not expected to be
different between the study groups.
Phase:
Phase 1
Details
Lead Sponsor:
Daiichi Sankyo, Inc.
Treatments:
Mineralocorticoid Receptor Antagonists Moxifloxacin Norgestimate, ethinyl estradiol drug combination